Quince Therapeutics, Inc. (QNCX)
Healthcare
Biotechnology
25.30 $
+8.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Quince Therapeutics, Inc. (QNCX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -41 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -9.8 | -12 | -33 | -51 | -63 | -44 | -18 | -32 | -41 | |
| 0.0 | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 | 0.1 | |
| 0.0 | 0.2 | 2.1 | 14 | 30 | 17 | 5.2 | 4.7 | 5.1 | |
| – | 0.4 | 1.6 | 15 | 31 | 17 | – | – | – | |
| 0.5 | -0.4 | 1.9 | 10 | -4.3 | -9.8 | 2.0 | -0.5 | 13 | |
| 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | |
| -0.1 | -47 | -18 | -52 | 59 | 18 | -5.8 | 22 | 23 | |
| – | – | – | – | – | 17 | 64 | – | – | |
| – | 0.3 | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| 7.8 | 76 | 77 | 119 | 6.8 | 0.7 | 0.1 | -4.8 | 18 | |
| -2.2 | 17 | 26 | 16 | 2.9 | -25 | -24 | -15 | -0.4 | |
| -9.9 | -12 | -33 | -51 | -63 | -44 | -18 | -32 | -42 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.